中国药业
中國藥業
중국약업
CHINA PHARMACEUTICALS
2015年
11期
28-30
,共3页
陆伟%林婧%徐秀秀%桂鸣
陸偉%林婧%徐秀秀%桂鳴
륙위%림청%서수수%계명
1-磷酸鞘氨醇%原代骨髓间充质干细胞%增殖%分化
1-燐痠鞘氨醇%原代骨髓間充質榦細胞%增殖%分化
1-린산초안순%원대골수간충질간세포%증식%분화
sphingosine-1-phosphate(S1P)%primary bone marrow mesenchymal stem cells(PR-MSCs)%proliferation%differentiation
目的:探讨1-磷酸鞘氨醇(S1P)在骨髓间充质干细胞增殖及诱导分化为血管内皮细胞中的作用。方法采用S1P预处理原代骨髓间充质干细胞( PR-MSCs ),并评估S1P对PR-MSCs增殖和分化的影响。结果 S1P能显著促进PR-MSCs的增殖,促进PR-MSCs经血管内皮生长因子( VEGF )诱导分化为血管内皮细胞,这与经S1P处理后的PR-MSCs表达VEGF及Angiopointin-1的mRNA增多有关,同时P-ERK1/2高表达于S1P预处理后的PR-MSCs中。结论 S1P能促进PR-MSCs的增殖和分化为血管内皮细胞,并且S1P通过ERK通路影响PR-MSCs的旁分泌,这将促进PR-MSCs的临床应用以及加强对S1P作用机制的了解。
目的:探討1-燐痠鞘氨醇(S1P)在骨髓間充質榦細胞增殖及誘導分化為血管內皮細胞中的作用。方法採用S1P預處理原代骨髓間充質榦細胞( PR-MSCs ),併評估S1P對PR-MSCs增殖和分化的影響。結果 S1P能顯著促進PR-MSCs的增殖,促進PR-MSCs經血管內皮生長因子( VEGF )誘導分化為血管內皮細胞,這與經S1P處理後的PR-MSCs錶達VEGF及Angiopointin-1的mRNA增多有關,同時P-ERK1/2高錶達于S1P預處理後的PR-MSCs中。結論 S1P能促進PR-MSCs的增殖和分化為血管內皮細胞,併且S1P通過ERK通路影響PR-MSCs的徬分泌,這將促進PR-MSCs的臨床應用以及加彊對S1P作用機製的瞭解。
목적:탐토1-린산초안순(S1P)재골수간충질간세포증식급유도분화위혈관내피세포중적작용。방법채용S1P예처리원대골수간충질간세포( PR-MSCs ),병평고S1P대PR-MSCs증식화분화적영향。결과 S1P능현저촉진PR-MSCs적증식,촉진PR-MSCs경혈관내피생장인자( VEGF )유도분화위혈관내피세포,저여경S1P처리후적PR-MSCs표체VEGF급Angiopointin-1적mRNA증다유관,동시P-ERK1/2고표체우S1P예처리후적PR-MSCs중。결론 S1P능촉진PR-MSCs적증식화분화위혈관내피세포,병차S1P통과ERK통로영향PR-MSCs적방분비,저장촉진PR-MSCs적림상응용이급가강대S1P작용궤제적료해。
Objective To investigate the effects of sphingosine-1-phosphate ( S1P ) on the proliferation and differentiation of bone mar-row mesenchymal stem cells ( MSCs ) into vascular endothelial cells. Methods Primary bone marrow MSCs ( PR-MSCs ) were pre-treat-ed with S1P and the effects of S1P on the proliferation and differentiation of PR-MSCs was evaluated. Results The proliferation ca-pability of PR-MSCs was significantly enhanced by S1P. Furthermore, S1P accelerated the differentiation of PR-MSCs into endothelial cells under vascular endothelial growth factor ( VEGF ) induction, which was related with increasing mRNA production of VEGF and An-giopointin-1 in S1P-PR-MSCs. Meanwhile, P-ERK1/2 was highly expressed in S1P treated PR-MSCs. Conclusion S1P can pro-mote the proliferation and differentiation of PR-MSCs into vascular endothelial cells. In addition, S1P can affect paracrine of PR-MSCs by activating ERK pathway, which can promote the clinical application of PR-MSCS and strengthen the understanding on SIP action mechanism.